Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

Rhea-AI Summary

Chimerix (NASDAQ:CMRX) announced it will host a live conference call on March 2, 2023, at 8:30 a.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2022. The conference will provide insights into the company's performance and a business overview.

Participants can join the call by dialing (646) 307-1963 domestically or (800) 715-9871 internationally, using conference ID 9730865. An audio webcast will be accessible in the Investors’ section of Chimerix's website, with an archived version available two hours post-event.

Positive

• Anticipated financial results may indicate progress.
• Opportunity for direct engagement with investors through the conference call.

Negative

• No specific financial metrics or guidance provided ahead of the call.
• -

DURHAM, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, March 2, 2023 at 8:30 a.m. ET to report financial results for the fourth quarter and full-year ended December 31, 2022, and to provide a business overview.

To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 9730865. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.

CONTACTS:

Michelle LaSpaluto
919 972-7115
ir@chimerix.com

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com

Nick Lamplough / Dan Moore / Tanner Kaufman
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

FAQ

When is Chimerix's next conference call for financial results?

Chimerix's next conference call is scheduled for March 2, 2023, at 8:30 a.m. ET.

What will Chimerix discuss in the upcoming conference call?

Chimerix will report its financial results for the fourth quarter and full-year ended December 31, 2022, along with a business overview.

How can I access the Chimerix conference call?

You can access the conference call by dialing (646) 307-1963 domestically or (800) 715-9871 internationally, using conference ID 9730865.

Where can I find the archived version of the Chimerix conference call?

The archived version will be available on Chimerix's website approximately two hours after the live event.

What is the ticker symbol for Chimerix?

Chimerix's ticker symbol is CMRX.